Research Notes: FDA warning Lamictal Stevens-Johnson Syndrome

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

In-depth resource

FDA warning Lamictal Stevens-Johnson Syndrome — Research Summary — detailed background and analysis.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.